Company intelligence / Profile preview

PineBridge

Ownership: Private
Development stage: Other

Overview

PineBridge is most commonly known as PineBridge Investments, a global asset management firm rather than a life science, biotech, pharma, or healthcare operating company. Based on the requested name, the entity appears to be a financial services company focused on investment management across asset classes. It does not appear to have a drug-development pipeline, therapeutic programs, or healthcare products and services of the type typically associated with biotech or pharma company profiling. As a result, most biopharma-specific fields are not applicable.

Industry: Investors

Beyond the preview

Go deeper on PineBridge.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on PineBridge.

Explore the full profile